受机械影响的肺和肺气肿的进展。

IF 19.3 1区 医学 Q1 CRITICAL CARE MEDICINE American journal of respiratory and critical care medicine Pub Date : 2025-02-26 DOI:10.1164/rccm.202409-1820OC
Surya P Bhatt, Sandeep Bodduluri, Joseph M Reinhardt, Arie Nakhmani
{"title":"受机械影响的肺和肺气肿的进展。","authors":"Surya P Bhatt, Sandeep Bodduluri, Joseph M Reinhardt, Arie Nakhmani","doi":"10.1164/rccm.202409-1820OC","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Most emphysema is believed to arise from small airways disease, but recent data suggest emphysema begets more emphysema and that its progression may be due to the mechanical stress experienced by normal lung regions adjacent to existing emphysema.</p><p><strong>Objective: </strong>To determine whether new emphysema arises from this penumbra of mechanically affected lung (MAL) or from small airways disease.</p><p><strong>Methods: </strong>We co-registered inspiratory chest computed tomography (CT) scans acquired at enrollment and 5 years later in 4,972 participants enrolled in a multicenter cohort. Using adaptive Gaussian smoothing, we quantified the 3D effect of all emphysema clusters on adjacent normal voxels by assuming that the mechanical effect of each emphysema cluster on surrounding voxels depends on cluster size and decays with increasing distance. The cumulative mechanical effect on each voxel was used to calculate MAL. Based on the probability distribution of normal voxels progressing to emphysema, we classified voxels into High (≥10.5), Intermediate (>0 to <10.5), and Zero MAL. We co-registered baseline inspiratory and expiratory CT images to quantify functional small airways disease. We quantified the proportion of new emphysema arising from each risk region.</p><p><strong>Measurements and main results: </strong>In adjusted analyses, higher MAL was associated with faster FEV<sub>1</sub> decline (-2.2 ml/year, 95%CI -2.6 to -1.7; p<0.001) and emphysema progression (-0.14 g/L/year, 95%CI -0.16 to -0.12; p<0.001), and greater all-cause mortality (adjusted hazards ratio = 1.07, 95%CI 1.05-1.09; p<0.001). The relative mean contributions of high and intermediate MAL to new emphysema were 60.5% and 37.1%, respectively, in contrast to zero MAL (2.4%) and small airways disease (4.8%).</p><p><strong>Conclusions: </strong>Most new emphysema arises from areas of high MAL and in substantially higher proportion than areas of small airways disease.</p>","PeriodicalId":7664,"journal":{"name":"American journal of respiratory and critical care medicine","volume":" ","pages":""},"PeriodicalIF":19.3000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mechanically Affected Lung and Progression of Emphysema.\",\"authors\":\"Surya P Bhatt, Sandeep Bodduluri, Joseph M Reinhardt, Arie Nakhmani\",\"doi\":\"10.1164/rccm.202409-1820OC\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>Most emphysema is believed to arise from small airways disease, but recent data suggest emphysema begets more emphysema and that its progression may be due to the mechanical stress experienced by normal lung regions adjacent to existing emphysema.</p><p><strong>Objective: </strong>To determine whether new emphysema arises from this penumbra of mechanically affected lung (MAL) or from small airways disease.</p><p><strong>Methods: </strong>We co-registered inspiratory chest computed tomography (CT) scans acquired at enrollment and 5 years later in 4,972 participants enrolled in a multicenter cohort. Using adaptive Gaussian smoothing, we quantified the 3D effect of all emphysema clusters on adjacent normal voxels by assuming that the mechanical effect of each emphysema cluster on surrounding voxels depends on cluster size and decays with increasing distance. The cumulative mechanical effect on each voxel was used to calculate MAL. Based on the probability distribution of normal voxels progressing to emphysema, we classified voxels into High (≥10.5), Intermediate (>0 to <10.5), and Zero MAL. We co-registered baseline inspiratory and expiratory CT images to quantify functional small airways disease. We quantified the proportion of new emphysema arising from each risk region.</p><p><strong>Measurements and main results: </strong>In adjusted analyses, higher MAL was associated with faster FEV<sub>1</sub> decline (-2.2 ml/year, 95%CI -2.6 to -1.7; p<0.001) and emphysema progression (-0.14 g/L/year, 95%CI -0.16 to -0.12; p<0.001), and greater all-cause mortality (adjusted hazards ratio = 1.07, 95%CI 1.05-1.09; p<0.001). The relative mean contributions of high and intermediate MAL to new emphysema were 60.5% and 37.1%, respectively, in contrast to zero MAL (2.4%) and small airways disease (4.8%).</p><p><strong>Conclusions: </strong>Most new emphysema arises from areas of high MAL and in substantially higher proportion than areas of small airways disease.</p>\",\"PeriodicalId\":7664,\"journal\":{\"name\":\"American journal of respiratory and critical care medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":19.3000,\"publicationDate\":\"2025-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of respiratory and critical care medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1164/rccm.202409-1820OC\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory and critical care medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1164/rccm.202409-1820OC","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Mechanically Affected Lung and Progression of Emphysema.

Rationale: Most emphysema is believed to arise from small airways disease, but recent data suggest emphysema begets more emphysema and that its progression may be due to the mechanical stress experienced by normal lung regions adjacent to existing emphysema.

Objective: To determine whether new emphysema arises from this penumbra of mechanically affected lung (MAL) or from small airways disease.

Methods: We co-registered inspiratory chest computed tomography (CT) scans acquired at enrollment and 5 years later in 4,972 participants enrolled in a multicenter cohort. Using adaptive Gaussian smoothing, we quantified the 3D effect of all emphysema clusters on adjacent normal voxels by assuming that the mechanical effect of each emphysema cluster on surrounding voxels depends on cluster size and decays with increasing distance. The cumulative mechanical effect on each voxel was used to calculate MAL. Based on the probability distribution of normal voxels progressing to emphysema, we classified voxels into High (≥10.5), Intermediate (>0 to <10.5), and Zero MAL. We co-registered baseline inspiratory and expiratory CT images to quantify functional small airways disease. We quantified the proportion of new emphysema arising from each risk region.

Measurements and main results: In adjusted analyses, higher MAL was associated with faster FEV1 decline (-2.2 ml/year, 95%CI -2.6 to -1.7; p<0.001) and emphysema progression (-0.14 g/L/year, 95%CI -0.16 to -0.12; p<0.001), and greater all-cause mortality (adjusted hazards ratio = 1.07, 95%CI 1.05-1.09; p<0.001). The relative mean contributions of high and intermediate MAL to new emphysema were 60.5% and 37.1%, respectively, in contrast to zero MAL (2.4%) and small airways disease (4.8%).

Conclusions: Most new emphysema arises from areas of high MAL and in substantially higher proportion than areas of small airways disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
27.30
自引率
4.50%
发文量
1313
审稿时长
3-6 weeks
期刊介绍: The American Journal of Respiratory and Critical Care Medicine focuses on human biology and disease, as well as animal studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients. Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish clinical trials and outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Critical Care Perspectives or Pulmonary Perspectives. These are generally focused on a more limited area and advance a concerted opinion about care for a specific process. Concise Clinical Reviews provide an evidence-based synthesis of the literature pertaining to topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. Images providing advances or unusual contributions to the field are published as Images in Pulmonary, Critical Care, Sleep Medicine and the Sciences. A recent trend and future direction of the Journal has been to include debates of a topical nature on issues of importance in pulmonary and critical care medicine and to the membership of the American Thoracic Society. Other recent changes have included encompassing works from the field of critical care medicine and the extension of the editorial governing of journal policy to colleagues outside of the United States of America. The focus and direction of the Journal is to establish an international forum for state-of-the-art respiratory and critical care medicine.
期刊最新文献
Patient Dignity in Long-Term Recovery among Survivors of Acute Respiratory Failure: A Prospective Cohort Study. Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). Continuous On-Demand Diaphragm Neurostimulation to Prevent Diaphragm Inactivity During Mechanical Ventilation: A Phase 1 Clinical Trial (STIMULUS). Select Airway Specialized Pro-Resolving Mediators Are Associated with Recovery from Non-Viral COPD Exacerbations. Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized, Controlled Trial (RELIEF).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1